Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Incyte Corporation
University of Florida
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Children's Oncology Group
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Illinois at Chicago
City of Hope Medical Center
City of Hope Medical Center
Medical College of Wisconsin
City of Hope Medical Center
Shenzhen TargetRx, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
City of Hope Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Memorial Sloan Kettering Cancer Center
Nanfang Hospital, Southern Medical University
Roswell Park Cancer Institute
Northwestern University
Incyte Corporation
Roswell Park Cancer Institute
Takeda
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University Health Network, Toronto
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center